secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2026-06-12T20:15:32+00:00
Accession:  0001193125-26-269474
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Centessa shareholders approve Lilly acquisition; court sanction hearing June 22
-------------------------------------------------------------------------------

- Shareholders voted 126,653,456 for vs 23,007 against (99.98% of votes cast) to approve the scheme of arrangement.
- All seven shareholders of record voted in favor; no shareholder voted against.
- Court sanction hearing scheduled for June 22, 2026 at Royal Courts of Justice, London.
- Acquisition by Eli Lilly via court-sanctioned scheme expected to close following court approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000119312526269474/0001193125-26-269474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000119312526269474/d105373d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-269474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer